Search

Search Results

• Book

  Facilitating the genetic counseling process : practice-based skills. 2nd ed.

  by Patricia McCarthy Veach, Bonnie S. LeRoy, Nancy P. Callanan.

  Contents:
  Guidelines for Book Users: Instructors, Supervisors, and Students
  Overview of Genetic Counseling: History of the Profession and the Reciprocal Model of Practice
  Listening to Patients: Attending Skills
  Listening to Patients: Primary Empathy Skills
  Gathering Information: Asking Questions
  Structuring Genetic Counseling Sessions: Initiating, Contracting, Ending, and Referral
  Collaborating with Patients: Providing Information and Facilitating Patient Decision Making
  Responding to Patient Cues: Advanced Empathy and Confrontation Skills
  Patient Factors: Resistance, Coping, Affect, and Styles
  Providing Guidance: Advice and Influencing Skills
  Counselor Self-Reference: Self-Disclosure and Self-Involving Skills
  Genetic Counseling Dynamics: Transference, Countertransference, Distress, Burnout, and Compassion Fatigue
  Professionalism: Ethically-Based Reflective Practice
  Appendix A: ACGC (2015) Practice-Based Competencies
  Appendix B: NSGC Code of Ethics (2017).

  Digital Access ProQuest Ebook Central 2018
  Get Shareable Link

  View Details
• Article

  Note préliminaire sur l'effet anti-autistique, antidélirant et antihallucinatoire du teflutixol. [Preliminary note on the antiautistic, antidelusional and hallucinolytic effect of teflutixol (author's transl)].

  Bobon DP, Jaumoulle F, Bobon J.

  Acta Psychiatr Belg. 1977 Jul-Aug;77(4):530-46.

  The first thioxanthene derivative without the double bind up to now considered mandatory for the antipsychotic effect, teflutixol, was administered in a phase II pilot efficacy trial to acute or subacute psychotic inpatients (mean age 36,1) during at least 5 weeks at a dosage of 3 to 20 mg p.d. once a day. The patients were abruptly switched from a haloperidol baseline therapy, which was administered on an average for 3 weeks at 15 mg p.d. Preliminary results are reported for the first 11 patients on a purely clinical basis. Despite the limitations of a small sample and of a qualitative analysis of data, it is hypothesized that teflutixol is a potent and original neuroleptic drug combining at 6 mg p.d. or less potent antidelusional, hallucinolytic and antiautistic effects. Latency and duration of action approximate 2 days. At 6 mg and above appear side-effects of the desinhibiting type (anxious and/or aggressive mood, withdrawal, flaring up of delusions, insomnia, agitation) and extrapyramidal side-effects of the akathisia type. No adrenolytic, anticholinergic or toxic effects were prominent. The patient followed up for the longest period (6 months on 3 mg p.d.) has not relapsed and has normal liver functions.

  Digital Access Access Options
  Get Shareable Link

  PubMed